Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights

Go back to Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
(NASDAQ: XERS) Delayed: 9.10 +0.15 (1.68%)
Previous Close $8.95    52 Week High $ 
Open $8.99    52 Week Low $ 
Day High $9.15    P/E N/A 
Day Low $8.85    EPS $ 
Volume 1,546,958